Hydrogen peroxide-inducible clone-5 (Hic-5) is a focal adhesion scaffold protein primarily expressed in vascular and visceral smooth muscle cells. We recently generated mice lacking Hic-5, which grew with no apparent abnormality (Kim-Kaneyama J, et al. J Mol Cell Cardiol. 2011;50(1):77-86). However, we discovered that recovery of arterial media following vascular injury is delayed significantly in Hic-5 knockout mice consequent to enhanced apoptosis of cultured vascular smooth muscle cells after mechanical stress; thus, Hic-5 is regarded as a novel factor in vascular remodeling. The Hic-5 gene is also induced by transforming growth factor-β, a well-known accelerator in fibrosis. Hic-5 involvement in various fibrotic disorders, e.g., scar formation, keloid formation and glomerulosclerosis, has been proposed. siRNA silencing of Hic-5 in a breast cancer cell line reduces its invasiveness; moreover, Hic-5 serves as a steroid hormone co-activator and likely participates in endometriosis and prostate cancer. Thus, functional characterization of Hic-5 in various pathophysiological conditions may afford novel mechanistic insights into a wide variety of diseases.
Introduction
Focal adhesions, which are the cell surface complexes attaching to extracellular matrix (ECM), linking ECM and intracellular actin cytoskeleton, play key roles in cell adhesion, motility, morphological changes of cells and the signal transduction of multiple local environmental stimuli 1) . Focal adhesions consist of integrins and a series of focal adhesion proteins that function as adapters for integrins and actin cytoskeleton. Integrins penetrate the plasma membrane and directly interact with ECM at their extracellular domains, whereas integrins interact with focal adhesion proteins at their cytoplasmic domains (Fig. 1B a) . A continuing research thrust in focal adhesion biology has targeted the mechanisms governing signal transduction by the constituents of focal adhesions that lack apparent enzymatic activity such as kinases and phospholipases. In particular, the roles of focal adhesion proteins in vivo remain largely unexplored. We recently generated knockout mice lacking a focal adhesion protein, hydrogen peroxide-inducible clone-5 (Hic-5) 2) , which will serve as a powerful weapon for addressing the above question. The current review summarizes the molecular basis of Hic-5 and its implications in various pathophysiological conditions, including vascular remodeling and other disorders of various tissues.
Molecular and Cell Biology of Hic-5
Hic-5 is a focal adhesion protein expressed in smooth muscle cells of various tissues 3) . The hic-5 was originally isolated as a hydrogen peroxide-inducible gene as well as a transforming growth factor-β (TGF-β)-inducible gene, which encodes for a 444-amino acid protein 4) . This protein belongs to the paxillin family, which includes paxillin and leupaxin 5) . These proteins share principle structural domains such as the amino terminus LD domains and the four LIM domains of the carboxy terminus (Fig. 1A) . Many pre-actin stress fibers from focal adhesions in response to mechanical stress, thereby regulating the contractile capability of cells (Fig. 1B b) 3)
. The regulatory mechanisms responsible for subcellular trafficking of Hic-5 are largely unknown; however, Hic-5 possesses specific functions in different subcellular compartments as follows.
In the nucleus, Hic-5 participates in the transcriptional regulation of several genes (Fig. 1B c) [11] [12] [13] . For example, Hic-5 suppresses Lef/Tcf-driven transcription during vertebrate development; furthermore, vious investigations involving Hic-5 have been conducted in order to clarify the similarities and differences between paxillin and Hic-5 ( Table 1) . In fact, these two molecules share several binding proteins; however, additional studies are required to differentiate the roles of Hic-5 and paxillin [6] [7] [8] [9] . A previous study demonstrated that Hic-5 shuttles between the cytoplasm and nuclear compartments via an oxidant-sensitive nuclear export signal (NES), which overlaps one of the amino terminus LD domains 10) . Furthermore, Hic-5 was translocated to 
Hic-5 in Vascular Walls
Hic-5 is expressed in vascular smooth muscle cells (VSMCs) of various tissues. Accumulation of VSMCs in the intima of arteries is a key event in the development of neointimal hyperplasia, which causes restenosis following angioplasty. Previously, we analyzed the in vivo function of Hic-5, employing rodent models of vascular injury. The local delivery of Hic-5 in adenovirus vectors repressed injury-induced neointimal expansion in rat carotid arteries 21) . Forced expression of Hic-5 in cells embedded in the collagen gel matrix repressed uPA expression and cell migration, providing mechanistic insight into the repression of neointimal hyperplasia by Hic-5 in a rat model 21) . Thus, Hic-5 modulates cellular responses during neointimal hyperplasia in the vessel wall; this finding indicates that a focal adhesion molecule contributes to vascular repair and remodeling.
We utilized recently developed Hic-5 knockout mice to analyze differences from wild-type littermates, implementing comprehensive approaches including blood tests, micro-CT and histological examination of 42 organs in males and 44 organs in females in addition to observations based on a modified-SHIRPA method, which is a three-stage protocol for the comprehensive assessment of mouse behavior; however, it operates as a co-activator of steroid receptors via interaction with TIF-2, RAC3, CBP and p300 co-activators at glucocorticoid responsive promoters 12, [14] [15] [16] . Moreover, multiple sequences including GC/Sp1, Ets and ERE/AP-1 elements in the c-fos upstream are responsible for activation by Hic-5 11) . The P21 promoter region is also responsive to Hic-5 localized in the nucleus, which forms multi-protein transcriptional complexes with Sp1, Smad3 and p300 12) . In addition to its roles in the nucleus, Hic-5 serves as a scaffold of integrin signaling through interaction with multiple structural and signaling molecules such as FAK, PYK2/Cakβ, vinculin, GIT1, Csk and PTP-PEST at focal adhesions 6, 8, 9, 17) . A recent study regarding Hic-5 functions in focal adhesions revealed that Hic-5 is essential for adhesion formation in three-dimensional (3D) ECMs 18) . Additionally, Hic-5 is involved in VEGF-mediated chemotaxis and sheet migration into wounds via interaction with Traf4, which is implicated in the oxidative regulation of endothelial cell (EC) migration 19) . Other studies pertaining to Hic-5 have also focused on its functions at focal adhesions (Fig. 1B a) 19, 20) ; however, the physiological or pathophysiological conditions that endow Hic-5 with specific roles in different subcellular compartments remain unclear. these conditions. In a manner consistent with that of ECs, Hic-5 is localized in the cytoplasm adjacent to the cell boundary of VSMCs in the mouse femoral artery ( Fig. 3A and 3B) . Both ECs and VSMCs are major cellular components implicated in the development of various types of vascular disorders; consequently, investigations focusing on Hic-5 functions in vascular walls will afford novel pathophysiological findings of vascular cell adhesion to the surrounding ECM.
Hic-5 in Cancer, Fibrosis and Other Disorders
Hic-5 has been proposed as a target molecule of the novel anti-cancer reagent, 4-[N-[S-glutathionylacetyl]amino] phenylarsenoxide (GSAO), which is a hydrophilic derivative of the protein tyrosine phosphatase inhibitor phenylarsine oxide 22) . GSAO inhibits angiogenesis and tumor growth in mouse models. Treatment of human umbilical vein ECs with GSAO induced an upward mobility shift of the Hic-5 band on Western blotting, a finding indicative of increased phospho-tyrosine in Hic-5 protein by phosphatase inhibition. It is possible that GSAO modulates Hic-5 phosphorylation in ECs and suppresses angiogenesis. GSAO has entered a phase I clinical trial in the UK (ClinicalTrials.gov Identifier: NCT01147029).
Hic-5 knockdown by siRNA in the MDA-MB-231 breast cancer cell line induced an amoeboid Hic-5 knockout mice exhibited no apparent abnormality, and thus Hic-5 may not be essential for embryogenesis and development. Although Hic-5 knockout mice were apparently normal and fertile under physiological conditions, they displayed diminished capacity to recover from vascular injury 2) . Four weeks after vascular injury, the media area of the injured artery was significantly smaller in Hic-5 knockout mice than in wild-type mice. This altered vascular response was attributable to enhanced apoptosis of Hic-5-deficient VSMCs in response to mechanical stress. In addition, we found that Hic-5 is expressed not only in VSMCs but also in ECs (unpublished observation). Initial efforts involving immunohistochemical staining were unable to detect Hic-5 in ECs, probably due to the limitation of method sensitivity; however, we recently succeeded in detecting Hic-5 in ECs utilizing immunoelectron microscopy. Fig. 2A and 2B show the low-power field of a mouse pulmonary arteriole and the magnified image of an EC, respectively. Hic-5 was detected as gold colloid in the cytoplasm adjacent to the cell boundary facing ECM, indicating that Hic-5 is localized in focal adhesions in ECs. Consistent with the localization of Hic-5 at focal adhesions on the basement membrane side of endothelial cells, Hic-5 is involved in EC spread and migration. These cellular actions are important in various pathophysiological conditions such as angiogenesis, wound healing and capillary leak syndrome, indicating the crucial roles of Hic-5 in the regulation of and its involvement in endometriosis has been proposed 27) . Hic-5 mRNA expression in normal endometrium increases toward the end of the menstrual cycle. In contrast, Hic-5 expression at mRNA and protein levels was suppressed significantly in the late secretory endometrium, one of the four stages of the endometrium in the menstrual cycle, in patients with endometriosis. This observation may be functionally linked to progesterone resistance in patients with endometriosis. Consistently, cultured human endometrial stromal fibroblasts derived from endometriosis patients demonstrated blunted induction of Hic-5 due to cAMP treatment ("in vitro decidualization"). In addition to its role as a progesterone receptor co-activator, Hic-5 also serves as an androgen receptor co-activator. Castration of mice led to marked enhancement of Hic-5 expression in the prostate 28) . Hic-5 transfection into prostate cancer-derived LNCaP cells, which do not express Hic-5, suppressed growth of a tumor implanted into immunodeficient mice and restored the sensitivity of the tumor to therapeutic castration. Finally, involvement of Hic-5 in the pathogenesis of Alzheimer disease (AD) has been suggested 29) . Hic-5 expression was significantly greater in CA1 pyramidal neurons of AD hippocampi than in normal hippocampi. Moreover, Hic-5 was colocalized with pTau in neurofibrillary tangles in AD 29) . Although the contribution of Hic-5 to the initiation and progression of AD is not clear at present, Hic-5-mediated intracellular signaling from the ECM may play a role in the phenotype (increased circularity and decreased diameter) and weakened several of the properties typical of cancer cells, e.g., invasiveness through 3D ECMs, transendothelial migration into monolayers of bovine aortic ECs and metastasis to mouse lung in vivo 18) . In addition to hydrogen peroxide, Hic-5 is also induced by TGF-β, which acts in a key capacity in fibrosis after tissue injury. Following treatment of normal adult dermal fibroblasts (NADFs) with TGF-β, Hic-5 and smooth muscle α-actin were induced; furthermore, the NADF phenotype was altered to that of hypertrophic scar (myo)fibroblasts (HTSFs), which lost proliferative activity but highly expressed ECM proteins such as collagen and fibronectin. siRNA silencing of Hic-5 in TGF-β-treated NADFs or HTSFs led to the suppression of ECM protein production 23, 24) . These results suggested that Hic-5 plays crucial roles in the differentiation of fibroblasts, i.e., NADFs to HTSFs, and acceleration of fibrosis. In a rat model of glomerulosclerosis by subtotal nephrectomy, Hic-5 expression in glomeruli increased markedly; this phenomenon was accompanied by marked induction of type 1 collagen and elevated numbers of apoptotic cells, which suggested a pivotal role of Hic-5 in glomerulosclerosis 25) . Moreover, immunohistochemical staining of Hic-5 in keloid tissue revealed higher rates of expression than in control dermis 26) ; thus, Hic-5 likely functions as a key element in various types of fibrotic disorders.
Hic-5 is also a progesterone receptor co-activator in the aforementioned disorders may be linked to its ability to act as a modulator of TGF-β functions and to operate as a steroid hormone co-activator.
Conclusion
Focal adhesions are integrin-based structures that transmit signals between extracellular molecules and the cytoplasm. It is evident that cell adhesion occurs in vivo in 3D-matrix in a distinct fashion relative to focal adhesion in vitro in 2D cultures 30) . The recent generation of Hic-5 knockout mice enabled analysis of Hic-5 functions in a 3D-matrix state in vivo, thereby facilitating research into this molecule under physiological conditions. Hic-5 knockout mice exhibited an abnormal response to vascular injury, although these mice were normal without loading stress. Other studies regarding in vivo functions of Hic-5, in concert with our results, suggested that Hic-5 may play crucial roles in a variety of disorders such as vascular remodeling and cancer as well as fibrotic and steroid hormone-dependent diseases. These findings afford an enhanced understanding of the potential molecular mechanisms by which focal adhesion adaptor molecules modulate the development of various disorders. Based on a summation of the data, we propose a focal adhesion adaptor protein Hic-5 as a suitable novel therapeutic target for a wide variety of diseases.
